FIND EXCLUSIVE JOBS FROM €60,000
Press release published at The Swedish Wire
During July, 216,015 new B shares were issued in Elekta through the exercise of employee options distributed within the framework of the established employee option program.
The total number of shares in Elekta as of July 31, 2012 amounts to 95,701,670 divided between 3,562,500 A shares and 92,139,170 B shares.
One A share entitles the holder to ten votes and one B share to one vote.
For further information, please contact:
Johan Andersson Melbi, Investor Relations Manager, Elekta AB.
Tel: +46 702 100 451, email: email@example.com.
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 18.00 CET on July 31, 2012.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.
This information was distributed by Cision